FibroGen, Inc (NASDAQ:FGEN) on 2016-08-08 announced an EPS of $0.35. Estimates for the company’s EPS stand at $0.33. A week ago the earnings estimates stood at $0.33 changing by 0%, while a month ago they were $0.33.
The company had received an EPS estimate of $0.33 60 days ago while 90 days ago the estimates were at $0.33.
In the last 7 days the company has seen 4 upward revisions in its EPS estimates while the number of downward revisions was EPS_CNT_EST_REV_DOWN_LAST_7D:1835}}. Similarly, its EPS estimates were increased 4, 4, 4 and 4 times in the last 30, 60, 90 and 120 days respectively.
In the last 120, 90, 60 and 30 days periods the EP estimates were downgraded 4, 4, 4, 4 times.
In the previous 18 days the estimates saw upward revision 4 times and downward revision 4 times.
From a total of 4 estimates, the company’s mean EPS estimate for the period ended 2 stood at $0.33. As such the difference amount from the actual EPS was $0.02, which comes to 6.06%. Right before the announcement of the actual EPS, the estimates ha d a standard deviation of 0.13.
Coming to sales figures, FibroGen, Inc (NASDAQ:FGEN) is estimated to register annual sales of $22.102. The figure is the arithmetic mean of all estimates by 4 analysts while the median comes to $24.67 for the fiscal year 2016.
The highest estimate stands at $25.07 while lowest is $14. The annual sales estimate have a standard deviation of 5.406%.
In the last week 4 analysts increased their sales estimates while 4 decreased their estimates. The mean estimate changed by 0% from last week.
Over the last month, 4 analysts revised their estimates upwards while 4 analysts revised their estimates downwards. The mean estimate saw a change of 14.595% from a month ago.
Over the last 3 month period, 4 analysts revised their sales estimates for FibroGen, Inc (NASDAQ:FGEN) upwards while 4 analysts downgraded their estimates. The mean estimate from 3 months ago underwent a change of 14.595%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...